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1. Introduction 
The imbalance of chemical elements (CE) during the prenatal development of a foetus might 
cause foetal heart abnormalities and even miscarriages (Skalny, 1999; Kudriyn, 2000), while 
the deficit of many vital CE during the gestation period could lead to congenital heart 
diseases. The deficiency of Cu in the course of this period might provoke the development 
of aortic aneurysms and impairment of vessel elasticity (Panchenko, 2004), while the lack of 
Zn could bring about transposition of the great arteries (TGA) (Shankar & Prasad, 1998; 
Beerli et al., 2000). The content of Fe, Cu, Zn, Se and Mn in optimal quantities is 
indispensable for adequate support of the cellular cycle, growth and differentiation of cells, 
including cardiomyocytes (Ruff, 1999). TGA comprises a special group of congenital heart 
diseases (CHD) with concordant atrioventricular and discordant ventricular-arterial 
junctions (Fozzard et al., 1986; Hoffman, 2006). This complicated disease occurs in newborns 
with CHD in an excess of 10 % of cases, with significant mortality and morbidity (Bokeria & 
Gorbachevsky, 1996). This is because it is yet unclear why this disease occurs, how this 
pathology progresses during the growth and development of newborns and, most 
importantly, which metabolic processes get impaired in cardiomyocytes that lead to the 
death of myocardium. Nowadays, a high level of immunofluorescent methods allows for 
identifying the cardiomyocytes that are involved in DNA replication (Re, 1987; Bolli, 2002). 
The main difficulty encountered in treating this disease is to correctly evaluate the 
ventricular function providing an adequate cardiac output (Castaneda, 1993, 1998). Age is 
also an important factor in determining the speed and functional reaction of the 
myocardium to pressure overload (Isoyama et al., 1987; Re, 1987; Scholzen & Gerders, 2000). 
Further research is needed to answer the following questions: 1. How is CE distribution 
disrupted in different parts of the heart and how is this disruption related to 
pathomorphological abnormalities? 2. How are morphology and the molecular structure of 
cardiomyocytes changed in the course of growth and development of infants with TGA, 
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from newborns to 1-year-old babies? 3. What pathomorphological distinctions are typical for 
2 anatomical types of TGA: with intact ventricular septum (IVS) and with ventricular 
septum defect (VSD)? 
The purpose of this research is to study the content of chemical elements and the 
morphological structure of the myocardium in infants with different TGA types. Three tasks 
were set to achieve this goal: 1. To investigate some features of the content of CE and the 
structure of cardiomyocytes in 3 age groups: newborns aged 1 to 6 months and babies aged 
6 to 12 months. 2. To study the concentration of CE in different parts of the heart in infants 
with TGA and in patients whose death was not caused by cardiac problems (control group). 
3. To compare the features of CE and pathomorphological structure of 2 anatomic types of 
TGA: with atrial septal defect (ASD) and intact ventricular septum (IVS) and with atrial 
septal defects (ASD) and (VSD).   
2. Methods 
A pathomorphological  study was carried out using autopsy material of 68 infants aged 
under 1 who died during the follow-up period, as well as 10 infants of the same age whose 
death was not caused by cardiac problems. All TGA patients were broken down in 2 groups 
according to patients’ anatomical type: the first group included patients with a simple form 
of TGA – TGA with atrial septum defect (ASD) and intact ventricular septum (IVS) – 37 
patients (19 aged under 1 month and 18 aged 1 to 6 months), while 31 patients having TGA 
with ASD and VSD (7 aged under 1 month, 13 aged 1 to 6 months and 11 patients aged 6 
to12 months) were assigned to the second group.   
Biopsy samples were preserved in 4 % phosphate-buffered formalin and then washed off in 
a distilled water solution followed by processing in cryoprotectans (solutions of saccharose: 
5 % for 2 hours, 10 % for 2 hours, 15 % for 12 hours). Fluorometry of histologic specimens 
was carried out by using an Axioskop 40FL microscope and an AxioCamHRc camera.  To 
get a good computerized image of each histologic specimen, a Zeiss Plan-Neofluar x 40 lens 
was used for 20 s at a +24 °С room temperature. The images obtained were processed by 
AxioVision 3.1 software (Carl Zeiss).   
Fluorescent probes containing ethidium bromide and chlortetracycline were used to 
perform fluorometry of the myocardium. Staining myocardium slices with ethidium 
bromide was done in a phosphate buffer pH=7.4 that contained 5.0 * 10 3 g/l of ethidium 
bromide for 5 minutes at a temperature of 25 °С, while chlortetracycline, also done in a 
phosphate buffer pH=7.4 containing 2.6 * 10 2 g/l of chlortetracycline, was applied for 1 
minute at a temperature of 25 °С. Fluorometry of histological preparations was then carried 
out. In the case of ethidium bromide, uptake was equal to 510-523 nm, emission – to 595-605 
nm, while in the case of chlortetracycline, those parameters came to 400 nm and 520 nm 
respectively. In addition, myocardium samples were stained with antibodies for Monoclonal 
Anti Skeletal Myosin (FAST) Clone MY-32 skeletal myosin. FITS-conjugated secondary 
antibodies were used as a secondary marker.   
The following properties were measured: muscle fibre diameter, relative area of muscle 
tissue, its apparent density, number of nuclei, mean area of a nucleus, nucleus-cytological 
relations and number of intramyocardial vessels. 
Microsoft Excel 2000 was used to perform statistical processing of the results. T-tests were 
employed to provide the reliability of differences of mean quantities and correlation 
relationships. Differences p<0.05 were considered as reliable.   
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The concentrations of CE were determined by X-ray fluorescence analysis with synchronous 
radiation (SRXRF). All measurements were carried out at the station of X-ray fluorescent 
elemental analysis in the Siberian Centre of Synchrotron and Terahertz Radiation (Budker 
Institute of Nuclear Physics SB RAS). The parameters of the storage ring VEPP-3 and 
experimental station are as follows: Eex = 2 GeV, B = 2 T, Ie = 100 mA; chamber for the 
analysis is made from elconait; maximum diameter of the sample is 30 mm; the spot size is 1 
÷ 30 mm2; exposure time is 10 ÷ 1000 c; the excitation energy is from 12 to 45 keV; elements 
determined: from S to U; X-ray fluorescence from the sample is registered by 10mm2 Si(Li) 
detector (OXFORF, Oxford Instruments Inc., USA) with energy resolution 150 eV at 5.9 keV, 
respectively (Trounova et al., 1998).  
The advantages of the application of SR as a primary source of excitation are as follows: the 
high intensity → the better peak/background ratio → analysis of samples with low masses 
(down to 0.5 mg, dry weigh); linear polarization → lower background → lower detection 
limits (down to 0.02 ppm for organic matrices); the wide spectrum of radiation → 
optimization of excitation energy, the possibility to measure samples, as well as varying the 
excitation energy.  
The concentrations of CE in the samples of heart muscle and vessels were calculated by the 
external standard method (different certified reference materials [CRM]) were used). The 
corresponding approaches were elaborated upon, using different certified reference 
materials with similar matrices: the applicability of different standards and the absorption 
characteristics of their matrices were investigated (Trunova et al., 2008). All spectra obtained 
were processed by the AXIL programme (Canberra Packard, Benelux). The samples 
investigated are the fragments of myocardium tissue with masses from 2 to 10 mg (dry 
weigh). At one of the steps of the sample procedure they are dried for 48 hours and longer 
to obtain a dry sample with a flat surface.  
The content of CE was measured in 40 samples of myocardium of TGA infants aging from 1 
to 4.5 months (mean age 3.0+0.7 months, heart’s mass 54.0+5.0 g, body mass 4.2+0.3 kg). The 
concentrations of the following 14 CE were studied: S, Cl, K, Ca, Cr, Mn, Fe, Ni, Cu, Zn, Se, 
Br, Rb, Sr by SRXRF (Okuneva et al., 2010). By using X-ray fluorescence analysis with 
synchronous radiation (XFA SR), concentrations of the following 14 CE were studied: S, Cl, 
K, Ca, Cr, Mn, Fe, Ni, Cu, Zn, Se, Br, Rb, Sr (Okuneva et al., 2010). Myocardium samples 
were taken from ventricles and atria not later than 24 hours after death. Overall, more than 
270 X-ray fluorescence spectra of CE were obtained. The content of CE was determined on 
the basis of 1 µg per 1 g of tissue. 
3. The clinical examination of infants with TGA 
All patients with TGA were broken down in 2 groups: the first group included patients with 
intact ventricular septum (IVS), while the second one incorporated those with ventricular 
septum defects (VSD). Two tasks were set; firstly, to study the clinical characteristics of 
patients depending on their age, for which purpose all of them were classified into 3 age 
groups: newborns aged 1 to 6 months and babies aged 6 to12 months. The second task was 
to compare the clinical characteristics of the deceased patients (subgroup I) and patients 
with favourable outcomes after surgical repair of the disease (subgroup II). Anthropometric 
measurements of patients with IVS depending on their age in the first and second group are 
given in Table 1. 
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Group 
Sub 
group 
At birth By the time of surgery 
Weight, 
kg 
Height, 
cm 
Weight, 
kg 
Norm 
Height, 
cm 
Norm 
Newborns 
I (n=19) 3.2±0.6 50.4±3.2 3.1±0.1* 4.1±0.2 53.5±0.5 
52.8±0.2 
II (n=5) 3.2±0.1 52.0±1.3 3.2±0.1* 4.1±0.2 52.4±1.1 
1-6 months 
old 
I (n=18) 3.2±0.6 51.2±0.2 4.7±0.1 4.9±0.2 57.3±0.4 
55.8±0.2 
II (n=5) 3.1±0.2 51.0±1.3 5.3±0.9 4.9±0.2 58.8±3.1 
6 to 12 
months old 
II (n=5) 3.1±0.1 50.0±0.8 7.4± 0.7 9.5±0.2 70.2±3.0 70.5±0.2 
* Р < 0.05 
Table. 1. Anthropometric measurements of TGA patients with IVS 
As can be seen from Table 1, the weight of patients in all groups was close to the norm. 
However, by the moment of surgery the delay in body weight gain as compared to the norm 
in newborns in both subgroups amounted to 1000 g, in infants – 200 g, while in those who 
survived in the third group it came to 1500 g. Dynamics of height measurements slightly 
exceeded the benchmark indicators. Similar anthropometric data were also obtained for the 
VSD group (Table 2).  
 
 
Group 
Sub 
group 
At birth By the moment of surgery 
Weight, 
kg 
Height, 
cm 
Weight, 
kg 
Norm 
Height, 
cm 
Norm 
Newborns 
I 3,2±0,2 52,0±1,0 3,3±0,3 3,8±0,2 53,5±1,3 
52,8±0,2 
II 3,0±0,1 51,2±0,6 3,5±0,1 3,8±0,2 51,7±1,0 
1 to 6 
months old 
I 2,8±0,5 51,1±0,8 4,1±0,6* 5,0±0,2 58,1±2,5 
55,8±0,2 
II 3,2±0,1 50,8±0,2 4,0±0,1* 5,0±0,2 56,8±0,7 
6 to12 
months old 
I 3,4±0,4 50,6±1,2 6,0±0,8* 9,8±0,2 63,3±3,0 
70,5±0,2 
II 3,0±0,1 50,6±0,3 7,0±0,5* 9,4±0,2 70,5±2,1 
* Р < 0.05 
Table 2. Anthropometric measurements of TGA patients with VSD 
By the moment of surgery, the delay in body weight gain as compared with the norm in 
newborns was on average 400 g, in the 1 to 6 months old – 900 g, in 6 to 12 months old 
infants in the deceased subgroup this difference came to 3800 g, while in those who 
survived – 2400 g. Dynamics of height measurements slightly exceeded the benchmark 
indicators in both groups. Based on the data obtained, one might conclude that disruption of 
metabolic processes in TGA infants evidently manifests itself only by a decrease in body 
weight, with the height parameters remaining the same. Table 3 looks at echocardiographic 
(ECHO) measurement data in patients with IVS depending on their age. 
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Group Newborns 1 to 6 months old 6 to 12 months old 
Subgroup I II I II II 
End-systolic 
dimension, cm 
1.3±0.7 0.8±0.1 1.1±0.2 0.8±0.1 1.3±0.1 
End-systolic 
volume, ml 
1.4±0.7 1.4±0.7 3.8±1.5 1.7±0.5 5.8±1.0 
Systolic output, ml 6.0±2.1 4.6±1.0 20.4±13.6 7.3±1.9 16.9±1.7 
Shortening 
fraction, % 
44.1±4.9 51.2±2.1 40.7±6.6 47.2±2.2 48.0±5.1 
Ejection fraction, % 79.1±4.4 82.4±1.7 77.8±6.8 83.0±1.5 75.6±4.1 
LV thickness, сm 0.5±0.1 0.5±0.1 0.6±0.1 0.5±0.1 0.6± 0.1 
End-diastolic 
dimension, сm 1.6±0.2 1.5±0.1 2.0±0.3 1.7±01 2.5± 0.1 
End-diastolic 
volume,  ml 
8.6±3.0 5.6±1.8 19.1±8.7 6.5± 2.5* 22.7±3.6 
Table 3. Echocardiographic measurement data for TGA patients with IVS 
As the table shows, the age does not influence the following values of ECHO: RV end-
systolic dimension, LV shortening fraction and LV ejection fraction. There was a slight age-
related increase in ASD, as well as a decrease in the unclosed ductus arteriosus size. As 
compared with the newborns, the following ECHO values tended to increase: RV size, end-
systolic volume, systolic output, end-diastolic dimension, LV end-diastolic volume and LV 
thickness, thus indicating a reduction of myocardial contractility.  ECHO data on TGA 
patients with VSD are given in Table 4. 
 
Group Newborns 1 to 6 months old 6 to 12 months old 
Subgroup I II I II I II 
RV size, cm 1.2± 0.2 0.8± 0.1 1.0± 0.2 0.9± 0.2 1.5±0.4 1.4± 0.2 
End-systolic 
dimension, cm 
1.1± 0.3 1.2± 0.1 1.5± 0.4 1.3± 0.2 1.4±0.3 1.4± 0.2 
End-systolic 
volume, cm 
2.7±0.5 3.5± 0.9 9.4± 5.0 4.8±1.8 6.4± 2.3 6.4± 1.9 
Systolic output, 
ml 
10.1±3.5 9.3± 3.1 19.7±9.2 15.7±3.4 18.9±2.0 17.9±1.9 
Shortening 
fraction,% 
45.0±4.5 38.5±5.0 35.1±3.0 42.1±15.4 42.3±4.2 48.2±7.2 
Ejection 
fraction, % 
69.7±3.4 72.0±5.7 66.5±5.6 75.0±4.6 73.5±4.6 75.6±6.2 
LV thickness, 
Cm 
0.51±0.1 0.3± 0.1 0.54±0.1 0.5± 0.1 0.6±0.1 0.7± 0.1 
End-diastolic 
dimension, cm 
1.3± 0.3 1.9± 0.2 4.6± 3.3 2.4± 0.2 2.5±0.3 2.5± 0.2 
End-diastolic 
volume, cm 
11.6±1.5 13.3±4.6 25.8±11.9 20.6±5.0 24.2±5.9 22.7±4.8 
Table 4. Echocardiographic measurement data for TGA patients with VSD 
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In the 1 to 6 and 6 to 12 months old groups, as compared with the newborn group, the 
following ECHO values were found to increase considerably: RV size, end-systolic volume, 
systolic output, end-systolic dimension, end-diastolic volume and end-systolic dimension.  
In addition, there was a trend toward an increase in the size of ASD, VSD and LV thickness. 
However, the size of unclosed ductus arteriosus tended to decrease. The shortening fraction 
(SF) and ejection fraction (EF) values matched the age-related indices. The pressure in the 
pulmonary artery was elevated in all groups, but it was particularly high in the 6 to 12 
months old group.  
Clinical/functional examination of TGA patients demonstrated that in terms of basic clinical 
indicators there were no statistically significant differences between the deceased and 
surviving infants with TGA. Moreover, average indicators of all 3 age subgroups (newborns, 
1 to 6 months old and 6 to 12 months old) in both groups are identical within a time period. 
From this it follows that negative factors causing the death of infants with TGA are related 
to molecular disorders of metabolic processes in cardiomyocytes that, in turn, brought us to 
start studying the content of CE and structural/molecular characteristics of TGA infants’ 
myocardium.   
4. Distribution of chemical elements in different parts of the heart and their 
impact on the development of pathologies in TGA patients 
The following mechanisms were identified when analyzing the content of CE in the 
deceased infants’ myocardium (Table 5A,B). 
 
 
 Intact myocardium TGA patients’ myocardium 
Parts of 
the heart 
Left ventricle 
(n=5) 
Right ventricle 
(n=5) 
Left ventricle 
(n=15) 
Right ventricle 
(n=20) 
C
o
n
te
n
t 
o
f 
C
E
, µ
g
/
g
 
S 3380±631 3260±335 3268±424 3547±331 
Cl 842±311 624±142 405±45* 435±56 
K 792±257 630±133 508±60 560±55 
Ca 1352±218 1264±94 1256±89 1224±99 
Cr 1.0±0.22 0.9±0.12 0.4±0.15* 0.6±0.23 
Mn 2.4±0.2 2.4±0.2 2.6±0.8 5.1±2.0 
Fe 344±30 422±83 321±42 342±33 
Ni 0.4±0.05 0.6±0.09 0.2±0.03* 0.2±0.05* 
Cu 8.9±0.68 10.1±0.87 14.6±2.99 16.1±2.58 
Zn 360±39 392±43 240±22* 307±42 
Se 0.7±0.1 0.8±0.1 0.2±0.05* 0.1±0.04* 
Br 12±1.6 13±1.6 6±0.7* 8±0.8* 
Rb 1.4±0.23 1.4±0.18 0.8±0.20 0.6±0.08* 
Sr 6.1±0.7 6.3±0.6 3.7±0.7 3.8±0.5* 
 
* P < 0.05 
Table 5A. Distribution of CE in infants’ ventricle with intact myocardium and TGA infants  
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It follows from Tables 5A and 5B that in 65 % of TGA patients, as compared to those with 
intact myocardium, the content of CE was reduced: K was lower, down to 78 %, 
concentration of Cl, Cr, Sr, Zn decreased to 50 % and the concentration of Br, Ni, Rb was 
also low. The content of Se equalled to just 25 % of the benchmark value. Three CE: S, Ca 
and Fe had an appropriate concentration. It was found out that only 2 CE had an 
increased concentration: Cu – 160 % and Mn – 170 to 200 %. According to the distribution 
of CE in the heart parts, the lowest concentrations of CE were found in LV and RA 
myocardium.  
 
 
 
 Intact myocardium TGA patients’ myocardium 
Parts of 
the heart 
Left atrium 
(n=5) 
Right atrium 
(n=5) 
Left atrium 
(n=21) 
Right atrium 
(n=20) 
C
o
n
te
n
t 
o
f 
C
E
, µ
g
/
g
 
S 2560±180 2575±370 2398±300 2505±260 
Cl 504±83 615±158 348±43 290±42* 
K 494±71 580±165 444±58 421±38 
Ca 990±54 1112±96 1148±105 1109±86 
Cr 0.8±0.11 1.1±0.44 0.6±0.25 0.7±0.18 
Mn 2.0±0.2 2.0±0.2 3.1±1.1 4.2±1.4 
Fe 404±101 340±23 338±53 375±38 
Ni 0.3±0.06 0.4±0.09 0.2±0.04 0.2±0.04 
Cu 9.0±0.49 8.9±1.14 13.0±2.18 14.3±2.70 
Zn 344±38 298±57 183±21* 192±27 
Se 0.7±0.1 0.7±0.2 0.2±0.06* 0.2±0.05* 
Br 12±1.2 11±2.2 6±0.7* 6±0.6* 
Rb 1.2±0.17 1.1±0.24 0.5±0.10* 0.5±0.07* 
Sr 5.7±0.6 5.1±0.9 3.2±0.3* 3.5±0.4 
 
* P < 0.05 
Table 5B. Distribution of CE in infants’ atrium with intact myocardium and TGA infants  
Hence, irreversible hemodynamic disorders of the myocardial function and development 
of cardiac insufficiency might be connected with a low concentration of  Cl, Cr, Sr, Zn, Br, 
Rb, Ni and specifically Se, which in this case drops to 25 % and even beyond the 
measurement limit. An increased content of Mn and Cu mostly in the right parts of the 
heart could be explained by an elevated functional load and plays a compensatory role. 
The content of S, Fe and Ca matches the benchmark values and does not affect the 
changes in the myocardium. On the basis of the results obtained it may be concluded that 
in order to maintain normal functional activity of the myocardium in TGA infants, the 
content of Cl, Zn, Sr, Cr, Ni, Rb, Br and especially Se that protects cardiomyocytes from 
lipid peroxidation should be optimal.  The following relationships were revealed while 
comparing CE impoverishment in the myocardium of TGA infants in different heart parts 
(Table 6). 
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CE 
LV 
CE 
RV 
CE 
LA 
CE 
RA 
Mean m Mean m Mean m M m 
S 3268 424 S 3547 331 S 2398 330 S 2505 260 
Ca 1256 89 Ca 1224 99 Ca 1148 105 Ca 1109 86 
K 508 60 K 560 55 K 444 58 K 421 38 
Cl 405 45 Cl 435 56 Cl 348 43 Fe 375 38 
Fe 321 42 Fe 342 33 Fe 338 53 Cl 290 42 
Zn 240 22 Zn 307 42 Zn 183 21 Zn 192 27 
Cu 14.6 2.99 Cu 16 2.58 Cu 13 2.18 Cu 14.3 2.7 
Br 6 0.7 Br 8 0.8 Br 6 0.7 Br 6 0.6 
Sr 3.7 0.7 Mn 5.1 5 Sr 3.2 0.3 Mn 4.2 1.4 
Mn 2.6 0.8 Sr 3.8 0.5 Mn 3.1 1.1 Sr 3.5 0.4 
Rb 0.8 0.2 Rb 0.6 0.08 Cr 0.6 0.25 Cr 0.7 0.18 
Cr 0.4 0.15 Cr 0.6 0.23 Rb 0.5 0.1 Rb 0.5 0.07 
Ni 0.2 0.03 Ni 0.2 0.05 Se 0.2 0.06 Se 0.2 0.05 
Se 0.2 0.05 Se 0.1 0.04 Ni 0.2 0.04 Ni 0.2 0.04 
Table 6. CE impoverishment in the heart parts of TGA infants   
It was found that in the hypertrophied myocardium of LV (and RV) there was a decreased 
content of K, Cl, Zn, while the content of S, Fe and Ca remained at an adequate level (see 
Fig. 1). 
 
 
Fig. 1. Distribution of CE in LV of TGA infants, CE are arranged by concentration decrease. 
The concentration of microelements Cr, Rb, Ni, Se was notably lowered, while the 
remaining CE had values that were close to the benchmark ones. The data obtained led us to 
conclude that the hypertrophied myocardial function in TGA infants was impaired due to a 
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decreased concentration of microelements. These changes were more pronounced in the left 
parts of the heart. These results were also confirmed by the morphological examination 
data. Hypertrophic changes in the heart make rapid strides over age, exceeding the 
benchmark age values by 2 times at the age of up to 1 month and by 3.5 – 4.5 – at the age of 6 
to 12 months. At the same time, the linear dimensions of LV and RV in patients with IVS 
(first group) were practically identical, while in the VSD group (second group) the thickness 
of RV exceeded that of LV by 133 % (Table 7). 
 
Group 
Heart’s 
mass, 
g* 
Wall 
thickness, cm 
Muscle fibre 
diameter, µm 
Inflow, cm Outflow, cm 
RV LV RV LV RV LV RV LV 
1st 
group 
52.6 
±8.31 
0.60 
±0.15 
0.61 
±0.17 
11.65 
±2.12 
11.85
±1.95
2.5 
±0.41 
2.6 
±0.24 
3.6 
±0.61 
3.7 
±0.47 
2nd 
group 
48.7 
±9.33 
0.60 
±0.12 
0.55 
±0.14 
11.90 
±3.11 
11.60
±2.55
2.5 
±0.21 
2.8 
±0.36 
3.6 
±0.52 
4.0 
±0.54 
* The norm is 24±0.15 g  
Table 7. Cardiometric parameters of TGA newborns (first and second groups) 
 
Heart part Anatomic group S K Fe Cu Sr Zn 
RV 
1st group 0.15 0.09 0.58* -0.26 -0.19 0.12 
2nd group 0.31 0.15 -0.29 -0.60* 0.13 0.08 
LV 
1st group 0.92** 0.75** 0.82** -0.92** 0.67** -0.18 
2nd group 0.46 0.47 0.50 -0.33 0.30 -0.25 
* - Reliability of correlation relationship (p<0.05) 
** – Reliability of correlation relationship (p<0.01) 
Table 8. Correlation relationships (r) between myocardium thickness and content of some 
chemical elements  
A statistically reliable relationship between LV myocardium thickness and the content of S, 
K, Fe, Sr and a negative correlation relationship with Cu were revealed for the first group 
with IVS (Table 8). 
According to our data, an impaired myocardial function in TGA infants resulting in death 
might be related to a considerable reduction of metabolism, the markers of which appeared 
to be a lowered content of Br, Ni, Rb (down to 50 %), Cr, Sr, Zn, Cl (down to 60 %) and 
particularly Se (down to 25 %). What role do these CE play in myocardium metabolism in 
TGA infants? Some of these CE are mostly of an endonuclear nature (Cr, Mr, Ni), while 
others are found outside the nucleus and accumulated in microsomes, mitochondria, 
lysosomes and Golgi’s complex (Cu, Zn, Se, Br, Sr) (Kudrin et al., 2000). Of great importance 
is Zn, which activates more than 300 enzymes and is part of over 200 metalloproteins 
(Skalny, 1999; Beerli, 2000). Zinc deficiency results in the development of congenital heart 
diseases (Panchenko, 2004), Br plays an important role in the development of a foetus and 
its shortage leads to a greater number of miscarriages. Ni might be a co-factor of many 
enzymes: urease, hydrogenase, a number of dehydrogenases and methyl-coenzyme M-
reductase, while its deficiency affects metabolic processes in the cells. It was found out that 
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the activity of b-DNA-polymerase directly depends on the content of Cr, a vital chemical 
element (Panchenko, 2004). Cr deficiency is observed in premature infants, whose mothers 
do not get enough of it in their diet. Chlorous channels can be found in mitochondrial 
membranes and muscle tissue. Also, chloride ions regulate the liquid volume and stabilize 
pH of the cells (Sing & Snow, 1998). Rb is an analogue of K and together with Cl they are 
very active in redoxreactions. A considerable deficiency of Se, which protects 
cardiomyocytes from detrimental effects of free radicals, has the greatest impact on 
cardiomyocyte metabolism. A decrease in muscle mass and a developmental lag were 
observed in newborns whose mothers were short of Se during pregnancy (Panchenko et al., 
2004). In the case of Se deficiency, the cells start dying both in the form of apoptosis and 
necrosis, which might result in the sudden death of newborns (Azoicai et al., 1997; Bolli, 
2002). On the strength of these data, we suggest that a very low content of CE, and Se in 
particular, in the myocardium could lead to structural disorders in the development of heart 
parts and, consequently, to deaths among TGA infants.  
5. Pathomorphological measurements of myocardium in TGA infants 
Data on morphological measurements of myocardium samples of TGA infants and infants 
of the same age but with intact myocardium are given in Table 9. As is seen from Table 9, 
the myocardium mass increased by 2.0 – 2.5 times and it tended to increase over age, i.e. in 
TGA infants the increase in the heart’s mass considerably exceeded the normal age-related 
values for the heart’s mass. Morphometric measurement data show that, in comparison with 
the intact myocardium, the TGA infants’ myocardium had a reduced diameter of muscle 
fibres and a reduced mean area of nucleus and lowered nucleus-cytoplasma ratios in RV. 
However, the volumetric density and relative area of muscle tissue surface tended to 
increase.  
 
Morphometric 
parameters 
Heart part Infants TGA infants 
Muscle tissue 
diameter, µm 
LV 14.6±0.79 12.0±1.47 
RV 13.1±1.13 11.4±1.35 
Relative area of 
muscle tissue 
surface, µm² 
LV 265±22.8 287±27.3 
RV 274±27.3 286±37.6 
Volumetric density 
of muscle tissue 
LV 0.78±0.067 0.85±0.08 
RV 0.81±0.081 0.84±0.11 
Number of nuclei 
per field of vision 
LV 41±2.5 45±7.1 
RV 53±1.5 34±7.7 
Mean area of 
nucleus, µm² 
LV 2358±211.8 2073±107.1 
RV 2534±289.1 2063±355.8 
Nucleus-
cytoplasmic ratio 
LV 0.37 0.33 
RV 0.49 0.26 
Table 9. Morphometric parameters of TGA infants’ myocardium 
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Depending on the anatomic type, 2 groups of TGA patients prevail: the first group, the so-
called simple TGA form, TGA with atrial septal defect (ASD) and intact ventricular septum 
(IVS), and the second group, which includes TGA patients with ASD and VSD. 
From the point of view of hemodynamics, the first group of TGA patients with IVS features 
a two-directional shunt, the volume of which, when performing isolated shunting on the 
level of atria, will depend on compliance of atria, a pressure differential in them during 
different phases of the cardiac cycle, size of atrial defect and a difference in resistance of the 
systemic and pulmonary circulation. Since the systemic circulation and pulmonary 
circulation are separated, the main compensation strategy is to increase the volume of 
circulating blood, which leads to overflow of the pulmonary circulation system (Adkin et al., 
2002). In this anatomic type of TGA, the functional load on the ventricles is practically the 
same, which is confirmed by the results obtained while staining the myocardium with 
ethidium bromide. These results indicate that the peak of active synthesis of genetic material 
uptake in both ventricles in this group, as compared to that in the control group (see Fig. 
2A), occurs during the neonatal period and manifests itself as a dramatic drop in colour 
intensity in fluorescence (see Fig. 2B).  
The second group of TGA patients with VSD is hemodynamically characterized by the 
presence of 2 defects, on the level of atrial and ventricular septa, which improves blood 
mixing on the ventricular level due to crossed shunting. With VSD size being small, the 
pressure in pulmonary circulation grows slightly, when the size of VSD is large, the 
pressure in both circulation systems is levelled out which results in high pulmonary 
hypertension (HPHT) and augmentation of hypoxemia (Bokeria, 1996; Isoyama et al., 1987). 
In this anatomic type of TGA, due to an increase in the blood volume, both ventricles are 
subject to a large functional load as compared with the first group of patients, which makes 
itself evident in a reduced level of fluorescence in infancy (1 to 6 months old). From our 
point of view, this phenomenon can be defined as the start of the heart remodelling 
processes, which at the age of older than 6 months also include hyperplastic processes. 
These processes are related to polyploidization of nuclear material and subsequent 
hypertrophic phenomena determined by appropriate hemodynamic conditions developed 
during the postnatal period.  
 
 
Fig. 2A. Control group (up to 1 month). LV myocardium. Magnification 260. Filter set 14. 
BP510-560nm. FT580. LP 590nm. Staining with ethidium bromide. 
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Fig. 2B. TGA with IVS. Lowered fluorescence level. LV myocardium (1 to 6 months). 
Magnification 260. Filter set 14. BP510-560nm. FT580. LP 590nm. Staining with ethidium 
bromide. 
Clinical examination of TGA patients classified as belonging to the first anatomic type, i.e. 
with IVS, revealed an increase with age in cardiac insufficiency, respiration rate, liver 
dimensions, as well as a reduction in blood oxygen saturation on average, down to 
60.9+13.5%. Arterial pressure and cardiac rate were within the normal age limits.  
All TGA patients from the VSD group had pronounced cardiac insufficiency, increased 
respiration rate and liver dimensions, and decreased blood oxygen saturation, down to 32. 
5+12.5% (р<0.05 ). Arterial pressure and cardiac rate were within the normal age limits. 
According to echocardiographic data, TGA patients from both groups, as compared with 
newborns, tended to show with age an increase in the following indicators: RV size (end-
systolic dimension, stroke output, end-diastolic volume) and LV thickness. These changes 
imply a tendency towards a decrease in the contractile potential of the myocardium. The 
senior group of patients with VSD demonstrated a higher pressure in the pulmonary artery, 
up to 76.5+2.1 mm Hg. 
LV muscle mass was growing faster by 6 to 12 months in the patients with VSD, with this 
value remaining stable in the IVS group. The mean quantity of nuclei was initially lower 
than in the control group, while the average area of nuclei was, to the contrary, higher but 
tended to decrease with age as well.  The total area of nuclei in the control group tended to 
decrease. In the first group with IVS, this process took place faster, while in the second 
group there was an increase of this value, which is indicative of a compensatory reaction of 
LV. With age the surface density of cardiomyocytes smoothly grew in all the groups. The 
nucleus-cytoplasmic ratio in LV gradually decreased with age in infants of all groups. More 
pronounced was this tendency in RV of TGA patients with IVS. Conversely, a slight increase 
in this ratio was noted in TGA patients with VSD. 
Studying the number density of capillaries revealed their simultaneous changes in both 
groups, with the highest point occurring at the age of 1 month in LV and RV in patients with 
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IVS. Measuring the content of CE in groups with IVS and VSD resulted in the following 
findings. The content of Cu, Zn and Mn in the group with VSD is 1.3 – 1.5 times higher than 
in the group with IVS. The content of CE in LV and RV of patients with IVS was about the 
same, except for an increased content of Mn in LV. At the same time, the content of CE in 
RV of patients with VSD increased, compared with that in LV, notably higher were 
concentrations of Zn, Mn and, to a lesser extent, Cu, Cr, Br, Rb. These findings are also 
confirmed by the cardiometric data (see the Table). In the case of the type with IVS, 
hypertrophic processes in LV and RV develop uniformly, and CE concentrations in LV and 
RV do not differ essentially. In the second type of TGA with VSD, the right ventricle has to 
bear a large functional load, therefore, CE concentration in RV is higher than in LV. It agrees 
with more pronounced structural changes in coronary arteries in the functionally 
overloaded RV in patients with VSD. However, despite intensive cardiac work in the cases 
of ASD and VSD, oxygen delivery in this group of patients is worse because of lower blood 
oxygen saturation down to 32 %.   
The reduction of the numeric content of total ions Ca2+ is caused by the development of 
hypertrophic phenomena in the myocardium of patients with congenital heart diseases (see 
Fig. 3A and 3B). Most probably, these hypertrophic phenomena result from a decrease in the 
number of myofibrils, which aggravates cardiac insufficiency. 
 
 
 
 
 
 
 
 
 
Fig. 3A. Control group. Native sample of LV wall. A high level of fluorescence. Filter set 05. 
BP395-440nm. FT460. LP 470nm. Magnification 260. Staining with chlortetracycline. 
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Fig. 3B. TGA with IVS (6 to 12 months). Native sample of LV wall. A lowered level of 
fluorophore fluorescence. Filter set 05. BP395-440nm. FT460. LP 470nm. Magnification 260. 
Staining with chlortetracycline. 
In the case of hypertrophy not only is the volume (size) of muscle cells changed, but their 
phenotype as well. In the conditions of overload the contractile proteins in these cells are 
replaced by protein forms typical for foetuses and newborns. For example, the ß- myosin (ß- 
ǺǻС) heavy chain is activated and, simultaneously with the suppression of α-ǺǻС gene, 
the activity is changed over from the genes of the cardial α-actin to the genes of the skeletal 
one. This results in a reduction of the contractility speed of hypertrophied fibres. As 
hypertrophy proceeds, a few other genes are activated, including some early growth 
regulators, genes responding to thermal shock and growth factors, as well as a gene of the 
atrial natriuretic factor. The latter represents a peptide hormone that facilitates a decrease in 
hemodynamic overload by regulating blood pressure and salt discharge by the kidneys. 
Taking into account the preceding, we stained the myocardium samples with antibodies for 
Monoclonal Anti-Skeletal Myosin (FAST) Clone MY-32 skeletal myosin. As a secondary 
marker, we made use of FITS-conjugated secondary antibodies. As a result of the technique 
used, skeletal myosin was found in the myocardium of TGA patients (Fig. 4). 
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Fig. 4. TGA with IVS (1 to 6 months). Sample of LV wall. Appearance of skeletal myosin 
granules in the myocardial structure. Filter set 09. BP395-440nm. FT460. LP 470nm. 
Magnification  260. Monoclonal Anti-Skeletal Myosin (FAST) Clone MY-32, secondary 
antibody FITS-conjugated. 
Thus, considering the dynamics of intensity of the above morphological processes taking 
place in the myocardium of TGA infants not older than 1 year, it should be noted that 
hypertrophic changes in TGA patients’ myocardium make progress with age. Hyperplastic 
processes associated with intensive polyploidization of the genetic material and an increase 
in the quantity of desoxyribonucleic acid play an important role in the remodelling of the 
heart in patients older than 6 months. On the basis of fluorometric measurement data, the 
decrease in the level of total calcium ions in cardiomyocytes of TGA patients is dependent 
on the occurrence of cardiosclerosis zones when hypertrophy of the myocardium is 
progressing. While adapting to these processes and to chronic hypoxia typical for congenital 
heart diseases and due to a less energy-consuming mechanism of skeletal muscle 
contractility, the synthesis changes over from cardiac myosin to a skeletal one, which, in 
turn, enhances clinical presentations of cardiac insufficiency because of a lowered speed of 
hypertrophied fibre contractility. In the case of hypertrophy of cardiomyocytes, not only is 
their volume (size) changed, but their phenotype as well. The synthesis of the ß-myosin (ß-
ǺǻС) heavy chain is activated and, simultaneously with suppression of α-ǺǻС, the 
synthesis of cardio-specific proteins is changed over to proteins specific for skeletal muscles, 
for example, skeletal a-actin is expressed. This results in a reduction of the contractility 
speed of hypertrophied fibres. As hypertrophy proceeds, a few other genes are activated 
including some early growth regulators, genes responding to thermal shock and growth 
factors, as well as a gene of the atrial natriuretic factor, which facilitates a reduction in 
hemodynamic overload by regulating blood pressure and discharge of salt by the kidneys. 
Immunohistochemical examinations of the samples of TGA infants’ myocardium made it 
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possible to observe the appearance of skeletal myosin in the cardiomyocytes. This testifies 
that, during hypertrophy development, the synthesis changes over from cardiac myosin to a 
skeletal one. Plain fluorescent microscopy of preparations stained with ethidium bromide 
revealed a drastic decrease in intensity of the fluorescent marker in infants aged under 6 
months, as compared to the control group, and a rapid growth of ethidium bromide 
incorporation in infants aged 6 months and upward. It indicates a prevalence of the 
population of cardiomyocytes with diploid nuclei in the hearts of infants aged up to 6 
months. In patients aged above 6 months, the heart remodelling process proceeds, with the 
processes associated with polyploidization of nuclear material and subsequent development 
of cell hypertrophy dominating. It should be emphasized that the level of polyploidization 
in LV cardiomyocytes is essentially higher than that in RV. Hence, the hyperplastic 
processes associated with intensive polyploidization of the genetic material and an increase 
in the quantity of desoxyribonucleic acid play an important role in the remodelling of the 
heart in patients aged above 6 months. 
6. Conclusion 
This study enabled us to come to the following conclusion on the development of a 
pathological mechanism causing the deaths of TGA patients at an early age. As a result of 
aorta and pulmonary artery transposition, low-oxygen venous blood flows into the systemic 
circulation system, limits the growth of newborns. The need for a sufficient volume of 
oxygen can be met only by increased load on the myocardium, with the development of 
heart hypertrophy uniform for LV and RV in patients with IVS and more pronounced in RV 
in patients with VSD. In this case the growth of TGA infants conforms to the age norm and 
even slightly exceeds it, while the body mass falls far short of the norm by 25-30 %. For 
hypertrophy and hyperplasia to develop dramatically, there should be an increased supply 
of nutritional and caloric substances, including CE. As the delivery of CE turns out to be 
insufficient, or their consumption increases, a 50 % deficiency of such microelements as Cl, 
Cr, Sr, Zn, Br, Rb and especially Se, which, as an active antioxidant, protects cardiomyocytes 
from lipid peroxidation, can be seen.  As a consequence, structural disorders of the 
myocardium occur on the morphological/molecular level. Also observed are the following 
abnormalities: a decrease in the diameter of muscle fibres and the average area of nuclei, a 
drop in the level of the total calcium ions against the background of intensive 
polyploidization of genetic material, an increase in the content of the quantity of 
desoxyribonucleic acid, and change from the cardiac myosin synthesis over to a skeletal one.  
All these changes lead to alteration of the myocardium, occurrence of cardiosclerosis, 
development of cardiac insufficiency and reduction of arterial blood saturation down to 32 
% and below, which is fatal, and results in death of the organism. This is a picture of TGA 
development pathogenesis of infants from neonatal age up to 1 year old. In this case, only 
definitive repair of the disease can break the pathogenetic chain of TGA in an early period, 
and the best time when effective cardiac surgery could be performed for TGA infants is in 
the neonatal period.   
We suppose, that to prevent the development of congenital heart diseases including TGA, 
pregnant women and nursing mothers should get the optimum quantity of microelements 
Cr, Zn, Sr, Ni, Rb, Br and most of all Se, protecting the myocardium from lipid 
peroxidation. 
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